Search
Now showing items 1-3 of 3
Treatment of neoplastic disease with oral interferon
(United States. Patent and Trademark Office, 1998-10-20)
Neoplastic diseases are treated by the administration of human interferon, particularly IFN-α, at a dosage of from about 0.01 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and ...
Treatment of autoimmune disorders with oral interferon
(United States. Patent and Trademark Office, 1998-12-08)
Autoimmune disorders are treated by the administration of human interferon, particularly IFN-α or IFN-β, at a dosage of from about 0.01 to about 5 IU/lb./day such that the interferon is held in contact with the patient's ...
Low-dose oral administration of interferons
(United States. Patent and Trademark Office, 1999-06-08)
Improved methods for administering an interferon (IFN) to a warm-blooded vertebrate are described. The methods employ oral administration of the IFN to the vertebrate in very low dosages, for example, 0.1 to 1.5 IU per ...